The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients
Leprosy
About this trial
This is an interventional treatment trial for Leprosy focused on measuring Leprosy, Ulcers, Laser
Eligibility Criteria
Inclusion Criteria:
- presented with neuropathic ulcer
- attended at least 3 weekly appointments at the dressing service of UREMC
- completed specific multi-drug therapy for M. leprae
- gave written informed consent to participate in the study
Exclusion Criteria:
- clinically detectable infection in the ulcer
- use of drugs, like corticosteroids that could interfere with the wound healing process
- use of special dressings like hydrocolloid, calcium alginate, activated carbon or any kind of therapeutic procedure different from that used routinely for both groups of study
- non-attendance to therapeutic program (six sequential times or nine intercalated)
- pregnancy
- discomfort during treatment procedure
Sites / Locations
- Dr. Marcello Candia Reference Unit in Sanitary Dermatology of the State of Pará in Brazil (UREMC)
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
1
2
Subjects from the arm number 1 received routine treatment, including daily simple dressings with sterile gauze after wound cleaning with a 0.9% physiologic solution, use of 1% hydrophilic silver sulfadiazine cream (Prati Donaduzzi Laboratory, Toledo, Brazil) and orientation about the use of adapted footwear, self-care and the prevention of disabilities. Surgical debridement was done whenever indicated by nursing or orthopedic services from UREMC.
Subjects from the arm number 2 received low level laser therapy 3 times per week for 12 weeks, in addition to the same treatment as patients from the arm number 1.